The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across chemotherapy personalization, cell transplantation, multi-drug resistance studies, and adult stem cell regeneration. The corresponding clinical trials scenario related to monoclonal antibody drugs for autoimmune diseases is also depicted.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Table of Contents
1. Recent Advances in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies and Adult Stem Cell Regeneration
Chemotherapy Genetic Interaction Map for Personalized Treatment
Pancreatic Cell Transplant Capable of Vascularization
Decoding Acinetobacter Baumannii’s Multi-drug Resistance
Adult Stem Cell Regeneration by Fasting
2. Clinical Trial Analysis and Key Contacts
Clinical Trial Analysis of Monoclonal Antibody Drugs for Autoimmune Diseases
Key Contacts
